AVEO PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.2 - SECTION 906 CFO CERTIFICATION - August 6, 2010

Attached files

file filename
10-Q - FORM 10-Q - AVEO PHARMACEUTICALS, INC.d10q.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - AVEO PHARMACEUTICALS, INC.dex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - AVEO PHARMACEUTICALS, INC.dex311.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - AVEO PHARMACEUTICALS, INC.dex321.htm
EX-10.1 - FIRST AMENDMENT TO AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT - AVEO PHARMACEUTICALS, INC.dex101.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of AVEO Pharmaceuticals, Inc. (the “Company”) for the fiscal quarter ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, David Johnston, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that, to his knowledge on the date hereof:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 6, 2010

 

/s/ David B. Johnston

David B. Johnston

Chief Financial Officer

AVEO PHARMACEUTICALS, INC. Reports